Answer
Rystiggo (rozanolixizumab) is contraindicated in people with hypersensitivity to rozanolixizumab or any of its excipients.
Sources for this answer
- Rystiggo 140 mg/ml solution for injectionUCB Pharma Limited · emc · SmPC §4.3 Contraindications · Version 7Document updated
Sources checked